nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—Acetazolamide—glaucoma	0.414	1	CrCtD
Methazolamide—CA5A—glaucoma	0.108	0.513	CbGaD
Methazolamide—CA1—glaucoma	0.0583	0.277	CbGaD
Methazolamide—CA2—glaucoma	0.0442	0.21	CbGaD
Methazolamide—CA14—Diclofenamide—glaucoma	0.00959	0.0334	CbGbCtD
Methazolamide—CA14—Brinzolamide—glaucoma	0.00959	0.0334	CbGbCtD
Methazolamide—CA14—Dorzolamide—glaucoma	0.00926	0.0322	CbGbCtD
Methazolamide—CA6—Brinzolamide—glaucoma	0.0091	0.0317	CbGbCtD
Methazolamide—CA5A—Diclofenamide—glaucoma	0.0091	0.0317	CbGbCtD
Methazolamide—CA5A—Brinzolamide—glaucoma	0.0091	0.0317	CbGbCtD
Methazolamide—CA6—Diclofenamide—glaucoma	0.0091	0.0317	CbGbCtD
Methazolamide—CA5A—Dorzolamide—glaucoma	0.00879	0.0306	CbGbCtD
Methazolamide—CA6—Dorzolamide—glaucoma	0.00879	0.0306	CbGbCtD
Methazolamide—CA7—Brinzolamide—glaucoma	0.00794	0.0276	CbGbCtD
Methazolamide—CA5B—Diclofenamide—glaucoma	0.00794	0.0276	CbGbCtD
Methazolamide—CA5B—Brinzolamide—glaucoma	0.00794	0.0276	CbGbCtD
Methazolamide—CA7—Diclofenamide—glaucoma	0.00794	0.0276	CbGbCtD
Methazolamide—CA5B—Dorzolamide—glaucoma	0.00766	0.0267	CbGbCtD
Methazolamide—CA7—Dorzolamide—glaucoma	0.00766	0.0267	CbGbCtD
Methazolamide—CA12—Brinzolamide—glaucoma	0.00681	0.0237	CbGbCtD
Methazolamide—CA9—Brinzolamide—glaucoma	0.00681	0.0237	CbGbCtD
Methazolamide—CA12—Diclofenamide—glaucoma	0.00681	0.0237	CbGbCtD
Methazolamide—CA9—Diclofenamide—glaucoma	0.00681	0.0237	CbGbCtD
Methazolamide—CA14—Acetazolamide—glaucoma	0.0066	0.023	CbGbCtD
Methazolamide—CA12—Dorzolamide—glaucoma	0.00658	0.0229	CbGbCtD
Methazolamide—CA9—Dorzolamide—glaucoma	0.00658	0.0229	CbGbCtD
Methazolamide—CA1—Diclofenamide—glaucoma	0.00637	0.0222	CbGbCtD
Methazolamide—CA1—Brinzolamide—glaucoma	0.00637	0.0222	CbGbCtD
Methazolamide—CA6—Acetazolamide—glaucoma	0.00627	0.0218	CbGbCtD
Methazolamide—CA5A—Acetazolamide—glaucoma	0.00627	0.0218	CbGbCtD
Methazolamide—CA1—Dorzolamide—glaucoma	0.00615	0.0214	CbGbCtD
Methazolamide—CA4—Brinzolamide—glaucoma	0.00599	0.0208	CbGbCtD
Methazolamide—CA4—Diclofenamide—glaucoma	0.00599	0.0208	CbGbCtD
Methazolamide—CA4—Dorzolamide—glaucoma	0.00579	0.0201	CbGbCtD
Methazolamide—CA2—Brinzolamide—glaucoma	0.00551	0.0192	CbGbCtD
Methazolamide—CA2—Diclofenamide—glaucoma	0.00551	0.0192	CbGbCtD
Methazolamide—CA7—Acetazolamide—glaucoma	0.00546	0.019	CbGbCtD
Methazolamide—CA5B—Acetazolamide—glaucoma	0.00546	0.019	CbGbCtD
Methazolamide—CA2—Dorzolamide—glaucoma	0.00532	0.0185	CbGbCtD
Methazolamide—CA9—Acetazolamide—glaucoma	0.00469	0.0163	CbGbCtD
Methazolamide—CA12—Acetazolamide—glaucoma	0.00469	0.0163	CbGbCtD
Methazolamide—CA1—Acetazolamide—glaucoma	0.00438	0.0153	CbGbCtD
Methazolamide—CA4—Acetazolamide—glaucoma	0.00412	0.0143	CbGbCtD
Methazolamide—CA2—Acetazolamide—glaucoma	0.00379	0.0132	CbGbCtD
Methazolamide—CYP2E1—Pilocarpine—glaucoma	0.00238	0.00827	CbGbCtD
Methazolamide—CYP2D6—Carteolol—glaucoma	0.0015	0.0052	CbGbCtD
Methazolamide—SLC22A6—Acetazolamide—glaucoma	0.00146	0.00507	CbGbCtD
Methazolamide—Acetazolamide—CA5A—glaucoma	0.00103	0.513	CrCbGaD
Methazolamide—CYP2D6—Betaxolol—glaucoma	0.00101	0.00351	CbGbCtD
Methazolamide—CYP2C9—Diclofenamide—glaucoma	0.000973	0.00338	CbGbCtD
Methazolamide—CYP2C9—Dorzolamide—glaucoma	0.000939	0.00327	CbGbCtD
Methazolamide—CYP2C19—Timolol—glaucoma	0.000856	0.00298	CbGbCtD
Methazolamide—CYP3A4—Pilocarpine—glaucoma	0.000721	0.00251	CbGbCtD
Methazolamide—CYP2D6—Timolol—glaucoma	0.000651	0.00226	CbGbCtD
Methazolamide—CYP3A4—Brinzolamide—glaucoma	0.000566	0.00197	CbGbCtD
Methazolamide—Acetazolamide—CA1—glaucoma	0.000554	0.277	CrCbGaD
Methazolamide—CYP2D6—Clonidine—glaucoma	0.000553	0.00193	CbGbCtD
Methazolamide—CYP3A4—Dorzolamide—glaucoma	0.000546	0.0019	CbGbCtD
Methazolamide—Acetazolamide—CA2—glaucoma	0.00042	0.21	CrCbGaD
Methazolamide—CYP3A4—Acetazolamide—glaucoma	0.000389	0.00135	CbGbCtD
Methazolamide—CYP3A4—Clonidine—glaucoma	0.000352	0.00122	CbGbCtD
Methazolamide—Dyspepsia—Diclofenamide—glaucoma	0.000107	0.00226	CcSEcCtD
Methazolamide—Decreased appetite—Diclofenamide—glaucoma	0.000106	0.00223	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000105	0.00221	CcSEcCtD
Methazolamide—Paraesthesia—Levobunolol—glaucoma	0.000105	0.00221	CcSEcCtD
Methazolamide—Fatigue—Diclofenamide—glaucoma	0.000105	0.00221	CcSEcCtD
Methazolamide—Dyspepsia—Carbachol—glaucoma	0.000104	0.0022	CcSEcCtD
Methazolamide—Dysgeusia—Apraclonidine—glaucoma	0.000104	0.00219	CcSEcCtD
Methazolamide—Agranulocytosis—Dorzolamide—glaucoma	0.000104	0.00219	CcSEcCtD
Methazolamide—Erythema multiforme—Acetazolamide—glaucoma	0.000103	0.00217	CcSEcCtD
Methazolamide—Tinnitus—Acetazolamide—glaucoma	0.000102	0.00214	CcSEcCtD
Methazolamide—Haematuria—Pilocarpine—glaucoma	0.0001	0.00212	CcSEcCtD
Methazolamide—Feeling abnormal—Diclofenamide—glaucoma	0.0001	0.00211	CcSEcCtD
Methazolamide—Ill-defined disorder—Apraclonidine—glaucoma	9.84e-05	0.00208	CcSEcCtD
Methazolamide—Feeling abnormal—Levobunolol—glaucoma	9.62e-05	0.00203	CcSEcCtD
Methazolamide—Body temperature increased—Diclofenamide—glaucoma	9.6e-05	0.00203	CcSEcCtD
Methazolamide—Asthenia—Metipranolol—glaucoma	9.57e-05	0.00202	CcSEcCtD
Methazolamide—Malaise—Apraclonidine—glaucoma	9.56e-05	0.00202	CcSEcCtD
Methazolamide—Erythema multiforme—Dorzolamide—glaucoma	9.44e-05	0.00199	CcSEcCtD
Methazolamide—Body temperature increased—Carbachol—glaucoma	9.37e-05	0.00198	CcSEcCtD
Methazolamide—Tinnitus—Dorzolamide—glaucoma	9.31e-05	0.00196	CcSEcCtD
Methazolamide—Dysgeusia—Acetazolamide—glaucoma	9.29e-05	0.00196	CcSEcCtD
Methazolamide—Urticaria—Levobunolol—glaucoma	9.27e-05	0.00196	CcSEcCtD
Methazolamide—Tinnitus—Travoprost—glaucoma	9.27e-05	0.00196	CcSEcCtD
Methazolamide—Vertigo—Bimatoprost—glaucoma	9.24e-05	0.00195	CcSEcCtD
Methazolamide—Tinnitus—Brinzolamide—glaucoma	9.16e-05	0.00193	CcSEcCtD
Methazolamide—Discomfort—Apraclonidine—glaucoma	8.92e-05	0.00188	CcSEcCtD
Methazolamide—Dysgeusia—Brimonidine—glaucoma	8.92e-05	0.00188	CcSEcCtD
Methazolamide—Asthenia—Carteolol—glaucoma	8.86e-05	0.00187	CcSEcCtD
Methazolamide—Ill-defined disorder—Acetazolamide—glaucoma	8.8e-05	0.00186	CcSEcCtD
Methazolamide—Tinnitus—Pilocarpine—glaucoma	8.8e-05	0.00186	CcSEcCtD
Methazolamide—Asthenia—Diclofenamide—glaucoma	8.71e-05	0.00184	CcSEcCtD
Methazolamide—Malaise—Acetazolamide—glaucoma	8.55e-05	0.0018	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Betaxolol—glaucoma	8.54e-05	0.0018	CcSEcCtD
Methazolamide—Dysgeusia—Dorzolamide—glaucoma	8.51e-05	0.0018	CcSEcCtD
Methazolamide—Leukopenia—Acetazolamide—glaucoma	8.49e-05	0.00179	CcSEcCtD
Methazolamide—Dysgeusia—Travoprost—glaucoma	8.48e-05	0.00179	CcSEcCtD
Methazolamide—Rash—Metipranolol—glaucoma	8.41e-05	0.00177	CcSEcCtD
Methazolamide—Dermatitis—Metipranolol—glaucoma	8.4e-05	0.00177	CcSEcCtD
Methazolamide—Drowsiness—Clonidine—glaucoma	8.4e-05	0.00177	CcSEcCtD
Methazolamide—Asthenia—Levobunolol—glaucoma	8.38e-05	0.00177	CcSEcCtD
Methazolamide—Dysgeusia—Brinzolamide—glaucoma	8.37e-05	0.00177	CcSEcCtD
Methazolamide—Headache—Metipranolol—glaucoma	8.35e-05	0.00176	CcSEcCtD
Methazolamide—Convulsion—Acetazolamide—glaucoma	8.22e-05	0.00173	CcSEcCtD
Methazolamide—Diarrhoea—Carbachol—glaucoma	8.11e-05	0.00171	CcSEcCtD
Methazolamide—Dysgeusia—Pilocarpine—glaucoma	8.05e-05	0.0017	CcSEcCtD
Methazolamide—Ill-defined disorder—Travoprost—glaucoma	8.03e-05	0.00169	CcSEcCtD
Methazolamide—Diarrhoea—Levobunolol—glaucoma	7.99e-05	0.00169	CcSEcCtD
Methazolamide—Discomfort—Acetazolamide—glaucoma	7.98e-05	0.00168	CcSEcCtD
Methazolamide—Ill-defined disorder—Brinzolamide—glaucoma	7.93e-05	0.00167	CcSEcCtD
Methazolamide—Nausea—Metipranolol—glaucoma	7.92e-05	0.00167	CcSEcCtD
Methazolamide—Vertigo—Dorzolamide—glaucoma	7.81e-05	0.00165	CcSEcCtD
Methazolamide—Malaise—Travoprost—glaucoma	7.81e-05	0.00165	CcSEcCtD
Methazolamide—Confusional state—Acetazolamide—glaucoma	7.81e-05	0.00165	CcSEcCtD
Methazolamide—Vertigo—Travoprost—glaucoma	7.78e-05	0.00164	CcSEcCtD
Methazolamide—Paraesthesia—Apraclonidine—glaucoma	7.77e-05	0.00164	CcSEcCtD
Methazolamide—Anaphylactic shock—Acetazolamide—glaucoma	7.74e-05	0.00163	CcSEcCtD
Methazolamide—Headache—Carteolol—glaucoma	7.74e-05	0.00163	CcSEcCtD
Methazolamide—Vomiting—Diclofenamide—glaucoma	7.72e-05	0.00163	CcSEcCtD
Methazolamide—Malaise—Brinzolamide—glaucoma	7.71e-05	0.00163	CcSEcCtD
Methazolamide—Somnolence—Apraclonidine—glaucoma	7.69e-05	0.00162	CcSEcCtD
Methazolamide—Vertigo—Brinzolamide—glaucoma	7.68e-05	0.00162	CcSEcCtD
Methazolamide—Rash—Diclofenamide—glaucoma	7.66e-05	0.00162	CcSEcCtD
Methazolamide—Discomfort—Brimonidine—glaucoma	7.66e-05	0.00162	CcSEcCtD
Methazolamide—Headache—Diclofenamide—glaucoma	7.61e-05	0.00161	CcSEcCtD
Methazolamide—Vomiting—Carbachol—glaucoma	7.54e-05	0.00159	CcSEcCtD
Methazolamide—Rash—Carbachol—glaucoma	7.47e-05	0.00158	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Apraclonidine—glaucoma	7.47e-05	0.00158	CcSEcCtD
Methazolamide—Dermatitis—Carbachol—glaucoma	7.47e-05	0.00158	CcSEcCtD
Methazolamide—Fatigue—Apraclonidine—glaucoma	7.46e-05	0.00157	CcSEcCtD
Methazolamide—Somnolence—Bimatoprost—glaucoma	7.46e-05	0.00157	CcSEcCtD
Methazolamide—Headache—Carbachol—glaucoma	7.43e-05	0.00157	CcSEcCtD
Methazolamide—Dyspepsia—Bimatoprost—glaucoma	7.39e-05	0.00156	CcSEcCtD
Methazolamide—Leukopenia—Pilocarpine—glaucoma	7.35e-05	0.00155	CcSEcCtD
Methazolamide—Nausea—Carteolol—glaucoma	7.34e-05	0.00155	CcSEcCtD
Methazolamide—Headache—Levobunolol—glaucoma	7.31e-05	0.00154	CcSEcCtD
Methazolamide—Discomfort—Dorzolamide—glaucoma	7.31e-05	0.00154	CcSEcCtD
Methazolamide—Discomfort—Travoprost—glaucoma	7.28e-05	0.00154	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Bimatoprost—glaucoma	7.24e-05	0.00153	CcSEcCtD
Methazolamide—Nausea—Diclofenamide—glaucoma	7.21e-05	0.00152	CcSEcCtD
Methazolamide—Discomfort—Brinzolamide—glaucoma	7.19e-05	0.00152	CcSEcCtD
Methazolamide—Confusional state—Dorzolamide—glaucoma	7.15e-05	0.00151	CcSEcCtD
Methazolamide—Feeling abnormal—Apraclonidine—glaucoma	7.13e-05	0.0015	CcSEcCtD
Methazolamide—Anaphylactic shock—Dorzolamide—glaucoma	7.1e-05	0.0015	CcSEcCtD
Methazolamide—Nausea—Carbachol—glaucoma	7.04e-05	0.00149	CcSEcCtD
Methazolamide—Tinnitus—Clonidine—glaucoma	7.03e-05	0.00148	CcSEcCtD
Methazolamide—Paraesthesia—Acetazolamide—glaucoma	6.95e-05	0.00147	CcSEcCtD
Methazolamide—Nausea—Levobunolol—glaucoma	6.93e-05	0.00146	CcSEcCtD
Methazolamide—Discomfort—Pilocarpine—glaucoma	6.91e-05	0.00146	CcSEcCtD
Methazolamide—Somnolence—Acetazolamide—glaucoma	6.88e-05	0.00145	CcSEcCtD
Methazolamide—Rash—Latanoprost—glaucoma	6.83e-05	0.00144	CcSEcCtD
Methazolamide—Agranulocytosis—Betaxolol—glaucoma	6.82e-05	0.00144	CcSEcCtD
Methazolamide—Dermatitis—Latanoprost—glaucoma	6.82e-05	0.00144	CcSEcCtD
Methazolamide—Dyspepsia—Acetazolamide—glaucoma	6.81e-05	0.00144	CcSEcCtD
Methazolamide—Headache—Latanoprost—glaucoma	6.78e-05	0.00143	CcSEcCtD
Methazolamide—Anorexia—Dorzolamide—glaucoma	6.76e-05	0.00143	CcSEcCtD
Methazolamide—Confusional state—Pilocarpine—glaucoma	6.76e-05	0.00143	CcSEcCtD
Methazolamide—Decreased appetite—Acetazolamide—glaucoma	6.73e-05	0.00142	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Acetazolamide—glaucoma	6.68e-05	0.00141	CcSEcCtD
Methazolamide—Fatigue—Acetazolamide—glaucoma	6.67e-05	0.00141	CcSEcCtD
Methazolamide—Paraesthesia—Brimonidine—glaucoma	6.67e-05	0.00141	CcSEcCtD
Methazolamide—Somnolence—Brimonidine—glaucoma	6.61e-05	0.00139	CcSEcCtD
Methazolamide—Dyspepsia—Brimonidine—glaucoma	6.54e-05	0.00138	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Brimonidine—glaucoma	6.41e-05	0.00135	CcSEcCtD
Methazolamide—Fatigue—Brimonidine—glaucoma	6.41e-05	0.00135	CcSEcCtD
Methazolamide—Anorexia—Pilocarpine—glaucoma	6.39e-05	0.00135	CcSEcCtD
Methazolamide—Feeling abnormal—Acetazolamide—glaucoma	6.38e-05	0.00135	CcSEcCtD
Methazolamide—Paraesthesia—Dorzolamide—glaucoma	6.37e-05	0.00134	CcSEcCtD
Methazolamide—Somnolence—Dorzolamide—glaucoma	6.31e-05	0.00133	CcSEcCtD
Methazolamide—Paraesthesia—Brinzolamide—glaucoma	6.26e-05	0.00132	CcSEcCtD
Methazolamide—Dyspepsia—Dorzolamide—glaucoma	6.25e-05	0.00132	CcSEcCtD
Methazolamide—Dyspepsia—Travoprost—glaucoma	6.22e-05	0.00131	CcSEcCtD
Methazolamide—Asthenia—Apraclonidine—glaucoma	6.21e-05	0.00131	CcSEcCtD
Methazolamide—Somnolence—Brinzolamide—glaucoma	6.2e-05	0.00131	CcSEcCtD
Methazolamide—Decreased appetite—Dorzolamide—glaucoma	6.17e-05	0.0013	CcSEcCtD
Methazolamide—Urticaria—Acetazolamide—glaucoma	6.15e-05	0.0013	CcSEcCtD
Methazolamide—Dyspepsia—Brinzolamide—glaucoma	6.14e-05	0.0013	CcSEcCtD
Methazolamide—Body temperature increased—Acetazolamide—glaucoma	6.12e-05	0.00129	CcSEcCtD
Methazolamide—Fatigue—Dorzolamide—glaucoma	6.12e-05	0.00129	CcSEcCtD
Methazolamide—Tinnitus—Betaxolol—glaucoma	6.12e-05	0.00129	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Travoprost—glaucoma	6.1e-05	0.00129	CcSEcCtD
Methazolamide—Fatigue—Travoprost—glaucoma	6.09e-05	0.00129	CcSEcCtD
Methazolamide—Ill-defined disorder—Clonidine—glaucoma	6.09e-05	0.00128	CcSEcCtD
Methazolamide—Decreased appetite—Brinzolamide—glaucoma	6.06e-05	0.00128	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Brinzolamide—glaucoma	6.02e-05	0.00127	CcSEcCtD
Methazolamide—Paraesthesia—Pilocarpine—glaucoma	6.02e-05	0.00127	CcSEcCtD
Methazolamide—Asthenia—Bimatoprost—glaucoma	6.02e-05	0.00127	CcSEcCtD
Methazolamide—Fatigue—Brinzolamide—glaucoma	6.01e-05	0.00127	CcSEcCtD
Methazolamide—Somnolence—Pilocarpine—glaucoma	5.96e-05	0.00126	CcSEcCtD
Methazolamide—Diarrhoea—Apraclonidine—glaucoma	5.92e-05	0.00125	CcSEcCtD
Methazolamide—Malaise—Clonidine—glaucoma	5.92e-05	0.00125	CcSEcCtD
Methazolamide—Dyspepsia—Pilocarpine—glaucoma	5.9e-05	0.00125	CcSEcCtD
Methazolamide—Feeling abnormal—Dorzolamide—glaucoma	5.85e-05	0.00123	CcSEcCtD
Methazolamide—Decreased appetite—Pilocarpine—glaucoma	5.83e-05	0.00123	CcSEcCtD
Methazolamide—Feeling abnormal—Travoprost—glaucoma	5.82e-05	0.00123	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Pilocarpine—glaucoma	5.79e-05	0.00122	CcSEcCtD
Methazolamide—Feeling abnormal—Brinzolamide—glaucoma	5.75e-05	0.00121	CcSEcCtD
Methazolamide—Urticaria—Dorzolamide—glaucoma	5.64e-05	0.00119	CcSEcCtD
Methazolamide—Body temperature increased—Dorzolamide—glaucoma	5.61e-05	0.00118	CcSEcCtD
Methazolamide—Dysgeusia—Betaxolol—glaucoma	5.59e-05	0.00118	CcSEcCtD
Methazolamide—Agranulocytosis—Timolol—glaucoma	5.57e-05	0.00118	CcSEcCtD
Methazolamide—Asthenia—Acetazolamide—glaucoma	5.55e-05	0.00117	CcSEcCtD
Methazolamide—Urticaria—Brinzolamide—glaucoma	5.54e-05	0.00117	CcSEcCtD
Methazolamide—Feeling abnormal—Pilocarpine—glaucoma	5.53e-05	0.00117	CcSEcCtD
Methazolamide—Discomfort—Clonidine—glaucoma	5.52e-05	0.00116	CcSEcCtD
Methazolamide—Vomiting—Apraclonidine—glaucoma	5.5e-05	0.00116	CcSEcCtD
Methazolamide—Dermatitis—Apraclonidine—glaucoma	5.45e-05	0.00115	CcSEcCtD
Methazolamide—Headache—Apraclonidine—glaucoma	5.42e-05	0.00114	CcSEcCtD
Methazolamide—Confusional state—Clonidine—glaucoma	5.4e-05	0.00114	CcSEcCtD
Methazolamide—Asthenia—Brimonidine—glaucoma	5.33e-05	0.00112	CcSEcCtD
Methazolamide—Body temperature increased—Pilocarpine—glaucoma	5.3e-05	0.00112	CcSEcCtD
Methazolamide—Ill-defined disorder—Betaxolol—glaucoma	5.3e-05	0.00112	CcSEcCtD
Methazolamide—Diarrhoea—Acetazolamide—glaucoma	5.3e-05	0.00112	CcSEcCtD
Methazolamide—Rash—Bimatoprost—glaucoma	5.29e-05	0.00112	CcSEcCtD
Methazolamide—Dermatitis—Bimatoprost—glaucoma	5.29e-05	0.00112	CcSEcCtD
Methazolamide—Headache—Bimatoprost—glaucoma	5.26e-05	0.00111	CcSEcCtD
Methazolamide—Malaise—Betaxolol—glaucoma	5.15e-05	0.00109	CcSEcCtD
Methazolamide—Nausea—Apraclonidine—glaucoma	5.14e-05	0.00108	CcSEcCtD
Methazolamide—Vertigo—Betaxolol—glaucoma	5.13e-05	0.00108	CcSEcCtD
Methazolamide—Anorexia—Clonidine—glaucoma	5.1e-05	0.00108	CcSEcCtD
Methazolamide—Asthenia—Dorzolamide—glaucoma	5.09e-05	0.00107	CcSEcCtD
Methazolamide—Asthenia—Travoprost—glaucoma	5.07e-05	0.00107	CcSEcCtD
Methazolamide—Asthenia—Brinzolamide—glaucoma	5.01e-05	0.00106	CcSEcCtD
Methazolamide—Tinnitus—Timolol—glaucoma	5e-05	0.00105	CcSEcCtD
Methazolamide—Nausea—Bimatoprost—glaucoma	4.98e-05	0.00105	CcSEcCtD
Methazolamide—Vomiting—Acetazolamide—glaucoma	4.92e-05	0.00104	CcSEcCtD
Methazolamide—Diarrhoea—Dorzolamide—glaucoma	4.86e-05	0.00102	CcSEcCtD
Methazolamide—Headache—Acetazolamide—glaucoma	4.85e-05	0.00102	CcSEcCtD
Methazolamide—Diarrhoea—Travoprost—glaucoma	4.83e-05	0.00102	CcSEcCtD
Methazolamide—Asthenia—Pilocarpine—glaucoma	4.81e-05	0.00102	CcSEcCtD
Methazolamide—Paraesthesia—Clonidine—glaucoma	4.81e-05	0.00101	CcSEcCtD
Methazolamide—Discomfort—Betaxolol—glaucoma	4.8e-05	0.00101	CcSEcCtD
Methazolamide—Diarrhoea—Brinzolamide—glaucoma	4.77e-05	0.00101	CcSEcCtD
Methazolamide—Somnolence—Clonidine—glaucoma	4.76e-05	0.001	CcSEcCtD
Methazolamide—Confusional state—Betaxolol—glaucoma	4.7e-05	0.000992	CcSEcCtD
Methazolamide—Rash—Brimonidine—glaucoma	4.68e-05	0.000988	CcSEcCtD
Methazolamide—Dermatitis—Brimonidine—glaucoma	4.68e-05	0.000988	CcSEcCtD
Methazolamide—Headache—Brimonidine—glaucoma	4.65e-05	0.000982	CcSEcCtD
Methazolamide—Decreased appetite—Clonidine—glaucoma	4.65e-05	0.000982	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Clonidine—glaucoma	4.62e-05	0.000975	CcSEcCtD
Methazolamide—Fatigue—Clonidine—glaucoma	4.62e-05	0.000974	CcSEcCtD
Methazolamide—Nausea—Acetazolamide—glaucoma	4.6e-05	0.00097	CcSEcCtD
Methazolamide—Diarrhoea—Pilocarpine—glaucoma	4.59e-05	0.000968	CcSEcCtD
Methazolamide—Dysgeusia—Timolol—glaucoma	4.57e-05	0.000964	CcSEcCtD
Methazolamide—Vomiting—Dorzolamide—glaucoma	4.51e-05	0.000952	CcSEcCtD
Methazolamide—Rash—Dorzolamide—glaucoma	4.47e-05	0.000944	CcSEcCtD
Methazolamide—Dermatitis—Dorzolamide—glaucoma	4.47e-05	0.000943	CcSEcCtD
Methazolamide—Rash—Travoprost—glaucoma	4.45e-05	0.00094	CcSEcCtD
Methazolamide—Dermatitis—Travoprost—glaucoma	4.45e-05	0.000939	CcSEcCtD
Methazolamide—Headache—Dorzolamide—glaucoma	4.45e-05	0.000938	CcSEcCtD
Methazolamide—Anorexia—Betaxolol—glaucoma	4.44e-05	0.000938	CcSEcCtD
Methazolamide—Vomiting—Brinzolamide—glaucoma	4.44e-05	0.000936	CcSEcCtD
Methazolamide—Headache—Travoprost—glaucoma	4.43e-05	0.000934	CcSEcCtD
Methazolamide—Nausea—Brimonidine—glaucoma	4.41e-05	0.000931	CcSEcCtD
Methazolamide—Feeling abnormal—Clonidine—glaucoma	4.41e-05	0.000931	CcSEcCtD
Methazolamide—Rash—Brinzolamide—glaucoma	4.4e-05	0.000928	CcSEcCtD
Methazolamide—Dermatitis—Brinzolamide—glaucoma	4.39e-05	0.000927	CcSEcCtD
Methazolamide—Headache—Brinzolamide—glaucoma	4.37e-05	0.000922	CcSEcCtD
Methazolamide—Vomiting—Pilocarpine—glaucoma	4.26e-05	0.0009	CcSEcCtD
Methazolamide—Urticaria—Clonidine—glaucoma	4.25e-05	0.000898	CcSEcCtD
Methazolamide—Body temperature increased—Clonidine—glaucoma	4.23e-05	0.000893	CcSEcCtD
Methazolamide—Rash—Pilocarpine—glaucoma	4.23e-05	0.000892	CcSEcCtD
Methazolamide—Dermatitis—Pilocarpine—glaucoma	4.22e-05	0.000891	CcSEcCtD
Methazolamide—Nausea—Dorzolamide—glaucoma	4.21e-05	0.000889	CcSEcCtD
Methazolamide—Headache—Pilocarpine—glaucoma	4.2e-05	0.000886	CcSEcCtD
Methazolamide—Nausea—Travoprost—glaucoma	4.2e-05	0.000886	CcSEcCtD
Methazolamide—Vertigo—Timolol—glaucoma	4.19e-05	0.000885	CcSEcCtD
Methazolamide—Paraesthesia—Betaxolol—glaucoma	4.19e-05	0.000883	CcSEcCtD
Methazolamide—Nausea—Brinzolamide—glaucoma	4.14e-05	0.000874	CcSEcCtD
Methazolamide—Dyspepsia—Betaxolol—glaucoma	4.1e-05	0.000866	CcSEcCtD
Methazolamide—Decreased appetite—Betaxolol—glaucoma	4.05e-05	0.000855	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Betaxolol—glaucoma	4.02e-05	0.000849	CcSEcCtD
Methazolamide—Fatigue—Betaxolol—glaucoma	4.02e-05	0.000848	CcSEcCtD
Methazolamide—Nausea—Pilocarpine—glaucoma	3.98e-05	0.00084	CcSEcCtD
Methazolamide—Discomfort—Timolol—glaucoma	3.93e-05	0.000828	CcSEcCtD
Methazolamide—Asthenia—Clonidine—glaucoma	3.84e-05	0.000811	CcSEcCtD
Methazolamide—Feeling abnormal—Betaxolol—glaucoma	3.84e-05	0.000811	CcSEcCtD
Methazolamide—Confusional state—Timolol—glaucoma	3.84e-05	0.00081	CcSEcCtD
Methazolamide—Anaphylactic shock—Timolol—glaucoma	3.81e-05	0.000804	CcSEcCtD
Methazolamide—Urticaria—Betaxolol—glaucoma	3.7e-05	0.000781	CcSEcCtD
Methazolamide—Body temperature increased—Betaxolol—glaucoma	3.69e-05	0.000778	CcSEcCtD
Methazolamide—Diarrhoea—Clonidine—glaucoma	3.66e-05	0.000773	CcSEcCtD
Methazolamide—Anorexia—Timolol—glaucoma	3.63e-05	0.000766	CcSEcCtD
Methazolamide—Paraesthesia—Timolol—glaucoma	3.42e-05	0.000722	CcSEcCtD
Methazolamide—Vomiting—Clonidine—glaucoma	3.4e-05	0.000718	CcSEcCtD
Methazolamide—Somnolence—Timolol—glaucoma	3.39e-05	0.000714	CcSEcCtD
Methazolamide—Rash—Clonidine—glaucoma	3.38e-05	0.000712	CcSEcCtD
Methazolamide—Dermatitis—Clonidine—glaucoma	3.37e-05	0.000712	CcSEcCtD
Methazolamide—Headache—Clonidine—glaucoma	3.35e-05	0.000708	CcSEcCtD
Methazolamide—Dyspepsia—Timolol—glaucoma	3.35e-05	0.000707	CcSEcCtD
Methazolamide—Asthenia—Betaxolol—glaucoma	3.34e-05	0.000706	CcSEcCtD
Methazolamide—Decreased appetite—Timolol—glaucoma	3.31e-05	0.000699	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Timolol—glaucoma	3.29e-05	0.000694	CcSEcCtD
Methazolamide—Fatigue—Timolol—glaucoma	3.28e-05	0.000693	CcSEcCtD
Methazolamide—Diarrhoea—Betaxolol—glaucoma	3.19e-05	0.000673	CcSEcCtD
Methazolamide—Nausea—Clonidine—glaucoma	3.18e-05	0.000671	CcSEcCtD
Methazolamide—Feeling abnormal—Timolol—glaucoma	3.14e-05	0.000662	CcSEcCtD
Methazolamide—Urticaria—Timolol—glaucoma	3.03e-05	0.000638	CcSEcCtD
Methazolamide—Body temperature increased—Timolol—glaucoma	3.01e-05	0.000635	CcSEcCtD
Methazolamide—Vomiting—Betaxolol—glaucoma	2.96e-05	0.000625	CcSEcCtD
Methazolamide—Rash—Betaxolol—glaucoma	2.94e-05	0.00062	CcSEcCtD
Methazolamide—Dermatitis—Betaxolol—glaucoma	2.94e-05	0.00062	CcSEcCtD
Methazolamide—Headache—Betaxolol—glaucoma	2.92e-05	0.000616	CcSEcCtD
Methazolamide—Nausea—Betaxolol—glaucoma	2.77e-05	0.000584	CcSEcCtD
Methazolamide—Asthenia—Timolol—glaucoma	2.73e-05	0.000577	CcSEcCtD
Methazolamide—Diarrhoea—Timolol—glaucoma	2.61e-05	0.00055	CcSEcCtD
Methazolamide—Vomiting—Timolol—glaucoma	2.42e-05	0.000511	CcSEcCtD
Methazolamide—Rash—Timolol—glaucoma	2.4e-05	0.000507	CcSEcCtD
Methazolamide—Dermatitis—Timolol—glaucoma	2.4e-05	0.000506	CcSEcCtD
Methazolamide—Headache—Timolol—glaucoma	2.39e-05	0.000503	CcSEcCtD
Methazolamide—Nausea—Timolol—glaucoma	2.26e-05	0.000477	CcSEcCtD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.8e-05	0.000463	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CTSA—glaucoma	1.79e-05	0.000462	CbGpPWpGaD
Methazolamide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.78e-05	0.000459	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—SOD1—glaucoma	1.76e-05	0.000453	CbGpPWpGaD
Methazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	1.73e-05	0.000445	CbGpPWpGaD
Methazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.71e-05	0.000441	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CA2—glaucoma	1.69e-05	0.000437	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—CDKN2B—glaucoma	1.66e-05	0.000428	CbGpPWpGaD
Methazolamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.66e-05	0.000428	CbGpPWpGaD
Methazolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.65e-05	0.000424	CbGpPWpGaD
Methazolamide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.64e-05	0.000423	CbGpPWpGaD
Methazolamide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.63e-05	0.000419	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—IL1A—glaucoma	1.59e-05	0.000409	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CA1—glaucoma	1.48e-05	0.000381	CbGpPWpGaD
Methazolamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.46e-05	0.000377	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CTSA—glaucoma	1.43e-05	0.000369	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CA1—glaucoma	1.42e-05	0.000365	CbGpPWpGaD
Methazolamide—CA14—Metabolism—TXN—glaucoma	1.42e-05	0.000365	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—TXN—glaucoma	1.38e-05	0.000356	CbGpPWpGaD
Methazolamide—CA6—Metabolism—TXN—glaucoma	1.38e-05	0.000356	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CTSA—glaucoma	1.37e-05	0.000353	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CA2—glaucoma	1.35e-05	0.000348	CbGpPWpGaD
Methazolamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.35e-05	0.000347	CbGpPWpGaD
Methazolamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	1.34e-05	0.000346	CbGpPWpGaD
Methazolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.34e-05	0.000344	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CTSA—glaucoma	1.31e-05	0.000339	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—TXN—glaucoma	1.29e-05	0.000332	CbGpPWpGaD
Methazolamide—CA7—Metabolism—TXN—glaucoma	1.29e-05	0.000332	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—GSTT1—glaucoma	1.27e-05	0.000326	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CA2—glaucoma	1.24e-05	0.00032	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.2e-05	0.000309	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CA1—glaucoma	1.19e-05	0.000308	CbGpPWpGaD
Methazolamide—CA12—Metabolism—TXN—glaucoma	1.19e-05	0.000308	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CTSA—glaucoma	1.16e-05	0.000298	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GSTT1—glaucoma	1.1e-05	0.000283	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CA2—glaucoma	1.09e-05	0.000281	CbGpPWpGaD
Methazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.09e-05	0.00028	CbGpPWpGaD
Methazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.07e-05	0.000276	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GSTT1—glaucoma	1.07e-05	0.000276	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GSTT1—glaucoma	1.07e-05	0.000276	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—CYP1B1—glaucoma	1.01e-05	0.00026	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GSTT1—glaucoma	9.99e-06	0.000257	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GSTT1—glaucoma	9.99e-06	0.000257	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	9.94e-06	0.000256	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GSTT1—glaucoma	9.76e-06	0.000252	CbGpPWpGaD
Methazolamide—CA4—Metabolism—TXN—glaucoma	9.52e-06	0.000245	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—CDKN2A—glaucoma	9.5e-06	0.000245	CbGpPWpGaD
Methazolamide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	9.42e-06	0.000243	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTT1—glaucoma	9.25e-06	0.000239	CbGpPWpGaD
Methazolamide—CA2—Metabolism—TXN—glaucoma	9.12e-06	0.000235	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTT1—glaucoma	8.98e-06	0.000231	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	8.9e-06	0.000229	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NARFL—glaucoma	8.87e-06	0.000229	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA5A—glaucoma	8.87e-06	0.000229	CbGpPWpGaD
Methazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.8e-06	0.000227	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.78e-06	0.000226	CbGpPWpGaD
Methazolamide—CA1—Metabolism—TXN—glaucoma	8.75e-06	0.000225	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CYP1B1—glaucoma	8.75e-06	0.000225	CbGpPWpGaD
Methazolamide—CA14—Metabolism—ABCA1—glaucoma	8.75e-06	0.000225	CbGpPWpGaD
Methazolamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	8.59e-06	0.000221	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—ABCA1—glaucoma	8.52e-06	0.00022	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CYP1B1—glaucoma	8.52e-06	0.00022	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CYP1B1—glaucoma	8.52e-06	0.00022	CbGpPWpGaD
Methazolamide—CA6—Metabolism—ABCA1—glaucoma	8.52e-06	0.00022	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—CDKN1B—glaucoma	8.42e-06	0.000217	CbGpPWpGaD
Methazolamide—CYP2E1—Biological oxidations—GSTM1—glaucoma	8.06e-06	0.000208	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CYP1B1—glaucoma	7.96e-06	0.000205	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—ABCA1—glaucoma	7.96e-06	0.000205	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CYP1B1—glaucoma	7.96e-06	0.000205	CbGpPWpGaD
Methazolamide—CA7—Metabolism—ABCA1—glaucoma	7.96e-06	0.000205	CbGpPWpGaD
Methazolamide—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	7.95e-06	0.000205	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	7.78e-06	0.0002	CbGpPWpGaD
Methazolamide—CA9—Metabolism—TXN—glaucoma	7.69e-06	0.000198	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	7.67e-06	0.000198	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTT1—glaucoma	7.38e-06	0.00019	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ABCA1—glaucoma	7.37e-06	0.00019	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CYP1B1—glaucoma	7.37e-06	0.00019	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.27e-06	0.000187	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	7.15e-06	0.000184	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	7.09e-06	0.000183	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTT1—glaucoma	7.07e-06	0.000182	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	7.06e-06	0.000182	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—VEGFA—glaucoma	7e-06	0.00018	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	6.99e-06	0.00018	CbGpPWpGaD
Methazolamide—CA14—Metabolism—GSTM1—glaucoma	6.99e-06	0.00018	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NARFL—glaucoma	6.84e-06	0.000176	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA5A—glaucoma	6.84e-06	0.000176	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—GSTM1—glaucoma	6.82e-06	0.000176	CbGpPWpGaD
Methazolamide—CA6—Metabolism—GSTM1—glaucoma	6.82e-06	0.000176	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTT1—glaucoma	6.78e-06	0.000175	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.62e-06	0.000171	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GSTM1—glaucoma	6.36e-06	0.000164	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GSTM1—glaucoma	6.36e-06	0.000164	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA5A—glaucoma	6.29e-06	0.000162	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NARFL—glaucoma	6.29e-06	0.000162	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA5A—glaucoma	6.24e-06	0.000161	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NARFL—glaucoma	6.24e-06	0.000161	CbGpPWpGaD
Methazolamide—CYP2C19—Biological oxidations—GSTM1—glaucoma	6.22e-06	0.00016	CbGpPWpGaD
Methazolamide—CA14—Metabolism—MTHFR—glaucoma	6.18e-06	0.000159	CbGpPWpGaD
Methazolamide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	6.13e-06	0.000158	CbGpPWpGaD
Methazolamide—CA6—Metabolism—MTHFR—glaucoma	6.02e-06	0.000155	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—MTHFR—glaucoma	6.02e-06	0.000155	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTT1—glaucoma	5.96e-06	0.000154	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTM1—glaucoma	5.89e-06	0.000152	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ABCA1—glaucoma	5.88e-06	0.000152	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYP1B1—glaucoma	5.88e-06	0.000152	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.87e-06	0.000151	CbGpPWpGaD
Methazolamide—CA14—Metabolism—APOE—glaucoma	5.75e-06	0.000148	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTM1—glaucoma	5.72e-06	0.000147	CbGpPWpGaD
Methazolamide—CA14—Metabolism—CAV1—glaucoma	5.7e-06	0.000147	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.67e-06	0.000146	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	5.64e-06	0.000145	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ABCA1—glaucoma	5.64e-06	0.000145	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP1B1—glaucoma	5.64e-06	0.000145	CbGpPWpGaD
Methazolamide—CA7—Metabolism—MTHFR—glaucoma	5.62e-06	0.000145	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—MTHFR—glaucoma	5.62e-06	0.000145	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—APOE—glaucoma	5.61e-06	0.000145	CbGpPWpGaD
Methazolamide—CA6—Metabolism—APOE—glaucoma	5.61e-06	0.000145	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.59e-06	0.000144	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—CAV1—glaucoma	5.56e-06	0.000143	CbGpPWpGaD
Methazolamide—CA6—Metabolism—CAV1—glaucoma	5.56e-06	0.000143	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP1B1—glaucoma	5.4e-06	0.000139	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ABCA1—glaucoma	5.4e-06	0.000139	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—TP53—glaucoma	5.29e-06	0.000136	CbGpPWpGaD
Methazolamide—CA7—Metabolism—APOE—glaucoma	5.23e-06	0.000135	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—APOE—glaucoma	5.23e-06	0.000135	CbGpPWpGaD
Methazolamide—CA12—Metabolism—MTHFR—glaucoma	5.21e-06	0.000134	CbGpPWpGaD
Methazolamide—CA7—Metabolism—CAV1—glaucoma	5.19e-06	0.000134	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—CAV1—glaucoma	5.19e-06	0.000134	CbGpPWpGaD
Methazolamide—CA12—Metabolism—APOE—glaucoma	4.85e-06	0.000125	CbGpPWpGaD
Methazolamide—CA12—Metabolism—CAV1—glaucoma	4.8e-06	0.000124	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ABCA1—glaucoma	4.75e-06	0.000122	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP1B1—glaucoma	4.75e-06	0.000122	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTM1—glaucoma	4.7e-06	0.000121	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.68e-06	0.000121	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.61e-06	0.000119	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTM1—glaucoma	4.51e-06	0.000116	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA1—glaucoma	4.33e-06	0.000112	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTM1—glaucoma	4.32e-06	0.000111	CbGpPWpGaD
Methazolamide—CA14—Metabolism—NOS3—glaucoma	4.31e-06	0.000111	CbGpPWpGaD
Methazolamide—CA6—Metabolism—NOS3—glaucoma	4.2e-06	0.000108	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—NOS3—glaucoma	4.2e-06	0.000108	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CTSA—glaucoma	4.19e-06	0.000108	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MTHFR—glaucoma	4.15e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA5A—glaucoma	4.11e-06	0.000106	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NARFL—glaucoma	4.11e-06	0.000106	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MTHFR—glaucoma	3.98e-06	0.000103	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CA2—glaucoma	3.96e-06	0.000102	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PTGS2—glaucoma	3.94e-06	0.000102	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—NOS3—glaucoma	3.92e-06	0.000101	CbGpPWpGaD
Methazolamide—CA7—Metabolism—NOS3—glaucoma	3.92e-06	0.000101	CbGpPWpGaD
Methazolamide—CA4—Metabolism—APOE—glaucoma	3.87e-06	9.97e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PTGS2—glaucoma	3.84e-06	9.9e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PTGS2—glaucoma	3.84e-06	9.9e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CAV1—glaucoma	3.83e-06	9.88e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MTHFR—glaucoma	3.82e-06	9.84e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTM1—glaucoma	3.8e-06	9.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.74e-06	9.64e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—APOE—glaucoma	3.71e-06	9.56e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.69e-06	9.51e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CAV1—glaucoma	3.67e-06	9.47e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—NOS3—glaucoma	3.63e-06	9.36e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—glaucoma	3.59e-06	9.25e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—glaucoma	3.59e-06	9.25e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APOE—glaucoma	3.55e-06	9.16e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CAV1—glaucoma	3.52e-06	9.08e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—glaucoma	3.36e-06	8.65e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA1—glaucoma	3.34e-06	8.61e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—glaucoma	3.32e-06	8.57e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CTSA—glaucoma	3.24e-06	8.34e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APOE—glaucoma	3.13e-06	8.06e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CAV1—glaucoma	3.1e-06	7.98e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA1—glaucoma	3.07e-06	7.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA2—glaucoma	3.06e-06	7.88e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA1—glaucoma	3.05e-06	7.85e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.99e-06	7.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.99e-06	7.7e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CTSA—glaucoma	2.98e-06	7.67e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CTSA—glaucoma	2.95e-06	7.6e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NOS3—glaucoma	2.9e-06	7.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA2—glaucoma	2.81e-06	7.24e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TXN—glaucoma	2.79e-06	7.19e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA2—glaucoma	2.79e-06	7.18e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NOS3—glaucoma	2.78e-06	7.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.72e-06	7.02e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.72e-06	7.02e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NOS3—glaucoma	2.66e-06	6.86e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—glaucoma	2.65e-06	6.83e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—glaucoma	2.54e-06	6.55e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—glaucoma	2.44e-06	6.28e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NOS3—glaucoma	2.34e-06	6.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—glaucoma	2.16e-06	5.58e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TXN—glaucoma	2.15e-06	5.55e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—glaucoma	2.14e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA1—glaucoma	2.01e-06	5.18e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TXN—glaucoma	1.98e-06	5.1e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.96e-06	5.06e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TXN—glaucoma	1.96e-06	5.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.95e-06	5.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CTSA—glaucoma	1.95e-06	5.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA2—glaucoma	1.84e-06	4.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.79e-06	4.62e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.77e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCA1—glaucoma	1.72e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1B1—glaucoma	1.72e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—glaucoma	1.67e-06	4.3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—glaucoma	1.54e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—glaucoma	1.52e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—glaucoma	1.38e-06	3.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.35e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCA1—glaucoma	1.33e-06	3.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1B1—glaucoma	1.33e-06	3.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TXN—glaucoma	1.29e-06	3.34e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.23e-06	3.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCA1—glaucoma	1.22e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1B1—glaucoma	1.22e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—glaucoma	1.22e-06	3.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1B1—glaucoma	1.21e-06	3.13e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCA1—glaucoma	1.21e-06	3.13e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—glaucoma	1.13e-06	2.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAV1—glaucoma	1.12e-06	2.9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—glaucoma	1.06e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—glaucoma	1e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—glaucoma	9.78e-07	2.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—glaucoma	9.7e-07	2.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—glaucoma	9.4e-07	2.42e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—glaucoma	8.75e-07	2.26e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAV1—glaucoma	8.67e-07	2.23e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—glaucoma	8.64e-07	2.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—glaucoma	8.57e-07	2.21e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—glaucoma	8.5e-07	2.19e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—glaucoma	8.05e-07	2.07e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1B1—glaucoma	8e-07	2.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCA1—glaucoma	8e-07	2.06e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—glaucoma	7.98e-07	2.06e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAV1—glaucoma	7.97e-07	2.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAV1—glaucoma	7.9e-07	2.04e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—glaucoma	7.77e-07	2e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—glaucoma	6.55e-07	1.69e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—glaucoma	6.39e-07	1.65e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—glaucoma	6.03e-07	1.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—glaucoma	5.99e-07	1.55e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—glaucoma	5.98e-07	1.54e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—glaucoma	5.65e-07	1.46e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—glaucoma	5.51e-07	1.42e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—glaucoma	5.47e-07	1.41e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—glaucoma	5.26e-07	1.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAV1—glaucoma	5.21e-07	1.34e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—glaucoma	3.94e-07	1.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—glaucoma	3.6e-07	9.29e-06	CbGpPWpGaD
